Clinical Trial Update: A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 prospective clinical trial evaluating whether aliskiren can protect kidney function in hypertensive patients with IgA nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis
• Hypertension
• Iga Nephropathy

Drugs mentioned

• Aliskiren (Aliskiren)

Snippet

Sponsor: Kagawa University | Conditions: Glomerulonephritis, IGA, Hypertension | Phase 4 | Status: UNKNOWN